Current Event

2008 Overview
Day 1 
Day 2
PDF Download 
Press Pass 
Request Brochure

Complimentary White Paper

21st Century Pharma: Managing Current Challenges to Ensure Future Growth

Arrive early and attend The Sixth Annual
Strategic Resource Management Executive Forum
November 17-18, 2008
Philadelphia, PA

PM Pharma LIG

Bird and Bird

ClearTrials Logo


IPM Integrated Project Mgt

Portfolio Decisions

Portfolio Decisionware

SDG Life Sciences



Bio-IT World

The Scientist




Portfolio Management 2008

Bring Your Entire Team!
Contact Call David Cunningham at 781.972.5472 for group discounts and company rates.

Utilizing Corporate Portfolio Management to Stop Investile Dysfunction
Anand SanwalAnand Sanwal, Managing Director, Brilliont; Former VP, Investment Optimization & Strategic Business Analysis, American Express

Portfolio Management in the Pharmaceutical Commercialization Space
Poplin KroesePoplin Kroese, Senior Analyst, Portfolio Management Strategy Deployment, Merck & Co. 

Integrating Value into the Portfolio Decision-Making Framework
Jean LeeJean Lee, Director, WWD Portfolio Management, Pfizer; Co-developed with Lori S. Shafner, Vice President, Portfolio and Project Management, Pfizer
Valuing a Diverse Portfolio: The Move from Selling Medicines to Promoting Health
Marilyn MetcalfMarilyn Metcalf, Ph.D., Director, Quantitative and Decision Sciences, GlaxoSmithKline

Evolution of Resource Management Capability at a Large Biotechnology Company 
Matt RiddellMatthew Riddell, M.B.A., Associate Director, Research & Development Planning & Operations, Program & Alliance Management, Biogen Idec

Cost-Risk-Value Optimization – Enabling Drug Developers to “Do the right thing”
Stephen WilliamsStephen A. Williams, Ph.D., Partner, Decisionability LLC; Former Vice President and Worldwide Head of Clinical Technology, Pfizer

Strategic Resource Management: Go Beyond Fancy Charts and Truly Impact Strategic Business DecisionsChris Beck
Christopher Beck, Vice President, Program Resources and Decision Support, Shire Pharmaceuticals

Successful Portfolio Management within Discovery at AstraZeneca
RichardLawsonRichard Lawson, Ph.D., Global Head of Discovery Decision Support, Discovery Strategy and Performance, AstraZeneca Pharmaceuticals, Inc.

Development Program Prioritization-Allocating Limited Resources in Any Business Environment
Len FalsoneLen Falsone, PE, Economics Manager, EP Americas, Shell Exlporation and Production Company 

Aligning Strategic Capacity Management with Business Development in Healthcare Product Safety
Colin CornhillColin Cornhill, Senior Director, BRM Integration & Capacity Management, Johnson & Johnson Pharmaceutical R&D

Distinguished Faculty:

  • Murray Aitken, Senior Vice President, Healthcare Insight, IMS Health Inc.
  • Richard M. Bayney, Ph.D., President & Founder, Project & Portfolio Value Creation; Faculty, University of Pennsylvania
  • Sabine Bernotat-Danielowski, Ph.D., MBA, Executive Director, Decision Analysis, Daiichi Sankyo
  • Robin G. Foldesy, Ph.D., Vice President, Portfolio Management, Wyeth Research
  • Richard J. Heaslip, Ph.D., Vice President, Project & Portfolio Management, Wyeth Research
  • Peter Heinrich, Ph.D., CEO, Portfolio DecisionWare, Inc.
  • Jeff Hewitt, Senior Principal, SDG life sciences, a unit of IMS
  • Jennifer Hirsch, Associate Director, R&D Operations, Johnson & Johnson Pharmaceutical R&D
  • J. Mark Horn, Director, Finance and R&D Portfolio Management, Wyeth Consumer Healthcare
  • John I. Howell III, President, Portfolio Decisions, Inc.
  • Matthew Kiernan, Partner, Pharmica Consulting
  • Poplin Kroese, Senior Analyst, Portfolio Management Strategy Deployment, Merck & Co.
  • Maureen Martini, Senior Project Manager, Global Strategic Planning and Program Management, Shire Pharmaceuticals
  • Grant Morgan, Ph.D., PMP, Leader of R&D Metrics and Capacity Management, Allergan, Inc.
  • Chad Nikel, Director of Business Development, Integrated Project Management
  • Paul Ranky, Ph.D., Professor, Department of Industrial and Management Systems Engineering and IT, NJIT
  • James F. Resch, Ph.D., Director, Strategic Intelligence, Discovery Strategy and Performance, AstraZeneca
  • Otto Ritter, Ph.D., Associate Director, Global Discovery Information, AstraZeneca
  • Vladimir Shnaydman, Ph.D, President, ORBee Consulting
  • Michael Shulman, Editor/Analyst, ChangeWave
  • Daniel Smith, Vice President, Enrich Consulting
  • Lillian Warren, Chief Operating Officer, Portfolio Decisions, Inc.

Overview | Day 1 | Day 2 | Go to Strategic Resource Management Conference 

By Series:
By Region: